Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer

BMC Cancer

Table 2 Immunohistochemical staining for tumors stratified by anatomical sites

Variable	All patients		GB cancer		Bile duct cancer		p-value
	No.	%	No.	%	No.	%
P53 (n = 127)
Positive	72	56.7	32	61.5	40	53.3	0.231
Negative	55	43.3	20	38.5	35	46.7
Cyclin D1 (n = 131)
Positive	35	26.7	18	33.3	17	22.1	0.109
Negative	96	73.3	36	66.7	60	77.9
Survivin (n = 129)
Positive	54	41.9	20	37.7	34	44.7	0.271
Negative	75	58.1	33	62.3	42	55.3
TP (n = 120)
Positive	78	65.0	40	78.4	38	55.1	0.006
Negative	42	35.0	11	21.6	31	44.9
ERCC1 (n = 113)
Positive	39	34.5	18	36.7	21	32.8	0.406
Negative	74	65.5	31	63.3	43	67.2

GB, gallbladder; TP, thymidine phosphorylase; ERCC1, excision repair cross complementing protein 1

ISSN: 1471-2407